Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors in the central anxious system, conolidine modulates alternate molecular targets. A Science Improvements study discovered that conolidine interacts Using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability. https://conolidin-to-replace-trad60369.blog-ezine.com/39034631/what-does-alternative-natural-pain-relief-to-replace-traditional-painkillers-mean